We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Alexion Pharmaceuticals Plans Phase 3 Trial of Ultomiris for Severe COVID-19
Alexion Pharmaceuticals Plans Phase 3 Trial of Ultomiris for Severe COVID-19
Alexion Pharmaceuticals plans to initiate a global phase 3 clinical trial to evaluate Ultomiris (ravulizumab-cwvz) in hospitalized patients with severe COVID-19.